Twist Bioscience Investor Relations Material
Latest events
Q3 2024
Twist Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Twist Bioscience Corporation
Access all reports
Segment Data
Access more data
Revenue by
Product
NGS tools
Synthetic genes
Antibody discovery
Oligo pools
DNA libraries
Expenses by
Financials
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. It offers synthetic DNA-based tools for research and development applications in life sciences. The company also provides molecular biology solutions comprising molecular cloning, next generation sequencing libraries, protein expression, and gene synthesis solutions; cytometry solutions; and biologics solutions for preclinical study. It serves the biotechnology research, pharmaceuticals and drug discovery, diagnostics, chemical manufacturing, agriculture industries, as well as contract research organizations and academic institutions.
Key slides for Twist Bioscience Corporation
Q1 2024
Twist Bioscience Corporation
Q4 2023
Twist Bioscience Corporation
Latest articles
Deere & Company: Shaping the Future of Agriculture Since 1837
Detailing the history of agriculture and Deere & Company, all the way from 1837 to the present day.
25 Oct 2024
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Ticker symbol
TWST
Country
🇺🇸 United States